105 related articles for article (PubMed ID: 24927871)
41. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F
Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422
[TBL] [Abstract][Full Text] [Related]
42. Potentiation of immunologic responsiveness to dendritic cell-based tumor vaccines by recombinant interleukin-2.
Shimizu K; Fields RC; Redman BG; Giedlin M; Mulé JJ
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S67-75. PubMed ID: 10685663
[TBL] [Abstract][Full Text] [Related]
43. Effective antitumor immunity against murine gliomas using dendritic cells transduced with hTERTC27 recombinant adenovirus.
Gong HX; He L; Li XP; Wang YD; Li Y; Huang JJ; Wang Z; Xie D; Kung HF; Peng Y
Oncol Rep; 2012 Apr; 27(4):1163-9. PubMed ID: 22210010
[TBL] [Abstract][Full Text] [Related]
44. In vitro antitumor immune response induced by dendritic cells transduced with human livin α recombinant adenovirus.
Xie J; Guo X; Liu F; Luo J; Duan F; Tao X
Cell Immunol; 2015 Sep; 297(1):46-52. PubMed ID: 26140980
[TBL] [Abstract][Full Text] [Related]
45. [Anti-tumor immune response of dendritic cells transfected with wild-type p53 gene].
Liu HJ; Xin JB; Li ZY; Xiong XZ; Tao XN; Hu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Dec; 31(12):902-7. PubMed ID: 19134406
[TBL] [Abstract][Full Text] [Related]
46. Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunity in vivo.
Tüting T; DeLeo AB; Lotze MT; Storkus WJ
Eur J Immunol; 1997 Oct; 27(10):2702-7. PubMed ID: 9368629
[TBL] [Abstract][Full Text] [Related]
47. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
He T; Tang C; Xu S; Moyana T; Xiang J
Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
[TBL] [Abstract][Full Text] [Related]
48. Induction of T-cell immunity against Epstein-Barr virus-associated tumors by means of adenovirally transduced dendritic cells.
Sun H; Yao K; Chen Y; Zhou F
Chin Med J (Engl); 2004 Oct; 117(10):1558-63. PubMed ID: 15498383
[TBL] [Abstract][Full Text] [Related]
49. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity.
Nakamura M; Iwahashi M; Nakamori M; Ueda K; Matsuura I; Noguchi K; Yamaue H
Clin Cancer Res; 2002 Aug; 8(8):2742-9. PubMed ID: 12171908
[TBL] [Abstract][Full Text] [Related]
50. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
[TBL] [Abstract][Full Text] [Related]
51. [Ad hTRP2 - mediated immunity against melanoma is enhanced by dendritic cells pulsed with peptide].
Tan XH; Liu C; Wan YH
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):658-61. PubMed ID: 17274369
[TBL] [Abstract][Full Text] [Related]
52. Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines.
Wan Y; Bramson J; Pilon A; Zhu Q; Gauldie J
Cancer Res; 2000 Jun; 60(12):3247-53. PubMed ID: 10866318
[TBL] [Abstract][Full Text] [Related]
53. Enhanced antitumor immunity elicited by dendritic cell vaccines is a result of their ability to engage both CTL and IFN gamma-producing NK cells.
Karimi K; Boudreau JE; Fraser K; Liu H; Delanghe J; Gauldie J; Xing Z; Bramson JL; Wan Y
Mol Ther; 2008 Feb; 16(2):411-8. PubMed ID: 18059374
[TBL] [Abstract][Full Text] [Related]
54. Dendritic cell based PSMA immunotherapy for prostate cancer using a CD40-targeted adenovirus vector.
Williams BJ; Bhatia S; Adams LK; Boling S; Carroll JL; Li XL; Rogers DL; Korokhov N; Kovesdi I; Pereboev AV; Curiel DT; Mathis JM
PLoS One; 2012; 7(10):e46981. PubMed ID: 23056548
[TBL] [Abstract][Full Text] [Related]
55. Exosomes from Dendritic Cells Loaded with Chaperone-Rich Cell Lysates Elicit a Potent T Cell Immune Response Against Intracranial Glioma in Mice.
Bu N; Wu H; Zhang G; Zhan S; Zhang R; Sun H; Du Y; Yao L; Wang H
J Mol Neurosci; 2015 Jul; 56(3):631-43. PubMed ID: 25680514
[TBL] [Abstract][Full Text] [Related]
56. Glioma stem cell-targeted dendritic cells as a tumor vaccine against malignant glioma.
Ji B; Chen Q; Liu B; Wu L; Tian D; Guo Z; Yi W
Yonsei Med J; 2013 Jan; 54(1):92-100. PubMed ID: 23225804
[TBL] [Abstract][Full Text] [Related]
57. Delivery of dendritic cells engineered to secrete IFN-alpha into central nervous system tumors enhances the efficacy of peripheral tumor cell vaccines: dependence on apoptotic pathways.
Kuwashima N; Nishimura F; Eguchi J; Sato H; Hatano M; Tsugawa T; Sakaida T; Dusak JE; Fellows-Mayle WK; Papworth GD; Watkins SC; Gambotto A; Pollack IF; Storkus WJ; Okada H
J Immunol; 2005 Aug; 175(4):2730-40. PubMed ID: 16081851
[TBL] [Abstract][Full Text] [Related]
58. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells transduced with replication-defective recombinant adenovirus.
Matsui M; Moriya O; Abdel-Aziz N; Matsuura Y; Miyamura T; Akatsuka T
Vaccine; 2002 Dec; 21(3-4):211-20. PubMed ID: 12450696
[TBL] [Abstract][Full Text] [Related]
59. Combination of p53-DC vaccine and rAd-p53 gene therapy induced CTLs cytotoxic against p53-deleted human prostate cancer cells in vitro.
Saito H; Kitagawa K; Yoneda T; Fukui Y; Fujsawa M; Bautista D; Shirakawa T
Cancer Gene Ther; 2017 Jul; 24(7):289-296. PubMed ID: 28621316
[TBL] [Abstract][Full Text] [Related]
60. Activation of cytotoxic T lymphocytes against CML28-bearing tumors by dendritic cells transduced with a recombinant adeno-associated virus encoding the CML28 gene.
Xie LH; Sin FW; Cheng SC; Cheung YK; Chan KT; Xie Y; Xie Y
Cancer Immunol Immunother; 2008 Jul; 57(7):1029-38. PubMed ID: 18157497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]